Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)

Guangdong VTR Bio-Tech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	826.13	821.47	790.19	1,149	1,838	1,903
Other Revenue	4.73	4.73	5.83	24.81	53.95	11.98
Revenue	830.87	826.2	796.02	1,174	1,892	1,915
Revenue Growth (YoY)	3.46%	3.79%	-32.20%	-37.95%	-1.18%	-6.51%
Cost of Revenue	462.36	460.33	459.12	816.91	1,217	1,188
Gross Profit	368.5	365.87	336.9	357.1	675.22	726.32
Selling, General & Admin	256.42	249.87	273.98	329.93	465.35	328.93
Research & Development	106.01	109.32	99.82	99.87	129.78	122.83
Other Operating Expenses	11.1	2.85	8.72	16.36	24.61	21.93
Operating Expenses	372.71	363.48	365.74	445.99	654.69	488.05
Operating Income	-4.21	2.4	-28.83	-88.89	20.53	238.27
Interest Expense	-5.12	-6.51	-2.83	-19.76	-34.4	-46.57
Interest & Investment Income	14.86	15.5	27.89	175.88	1.78	11.55
Currency Exchange Gain (Loss)	2.66	2.66	0.65	15.31	-9.01	-11.87
Other Non Operating Income (Expenses)	-9.18	-0.87	-0.24	-1.87	-2.65	-2.54
EBT Excluding Unusual Items	-0.99	13.18	-3.35	80.67	-23.76	188.84
Impairment of Goodwill	-	-	-	-	-80.83	-
Gain (Loss) on Sale of Investments	0.92	9.36	5.38	8.89	-2.28	-
Gain (Loss) on Sale of Assets	-2.53	3.01	0.05	-0.06	-0.23	0.01
Asset Writedown	-8.05	-7.87	-12.95	-0.43	-1.64	-1.71
Other Unusual Items	13.6	14.09	12.15	16	20.02	44.83
Pretax Income	2.96	31.78	1.28	105.07	-88.72	231.97
Income Tax Expense	-4.64	-0.17	0.13	67.55	-3.29	29.64
Earnings From Continuing Operations	7.6	31.95	1.15	37.52	-85.43	202.34
Minority Interest in Earnings	-1.1	-0.86	-11.9	-19.29	-33.48	-40.63
Net Income	6.5	31.09	-10.75	18.23	-118.91	161.71
Net Income to Common	6.5	31.09	-10.75	18.23	-118.91	161.71
Net Income Growth	-66.94%	-	-	-	-	26.81%
Shares Outstanding (Basic)	491	490	491	490	490	466
Shares Outstanding (Diluted)	491	490	491	490	490	468
Shares Change (YoY)	-0.08%	-0.09%	0.15%	-0.01%	4.75%	10.41%
EPS (Basic)	0.01	0.06	-0.02	0.04	-0.24	0.35
EPS (Diluted)	0.01	0.06	-0.02	0.04	-0.24	0.35
EPS Growth	-66.92%	-	-	-	-	14.85%
Free Cash Flow	-262.43	-308.2	-239.77	51.99	53.95	120.68
Free Cash Flow Per Share	-0.54	-0.63	-0.49	0.11	0.11	0.26
Dividend Per Share	0.100	0.100	0.060	0.100	0.100	0.070
Dividend Growth	66.67%	66.67%	-40.00%	-	42.86%	16.67%
Gross Margin	44.35%	44.28%	42.32%	30.42%	35.69%	37.93%
Operating Margin	-0.51%	0.29%	-3.62%	-7.57%	1.08%	12.44%
Profit Margin	0.78%	3.76%	-1.35%	1.55%	-6.28%	8.45%
Free Cash Flow Margin	-31.59%	-37.30%	-30.12%	4.43%	2.85%	6.30%
EBITDA	107.82	114.28	82.84	48.96	188.39	393.59
EBITDA Margin	12.98%	13.83%	10.41%	4.17%	9.96%	20.56%
D&A For EBITDA	112.03	111.88	111.68	137.85	167.86	155.32
EBIT	-4.21	2.4	-28.83	-88.89	20.53	238.27
EBIT Margin	-0.51%	0.29%	-3.62%	-7.57%	1.08%	12.44%
Effective Tax Rate	-	-	9.92%	64.29%	-	12.78%
Revenue as Reported	830.87	826.2	796.02	1,174	1,892	1,915

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.